Sovaldi
SOFOSBUVIR
- Strength
- 150 mg/1
- Form
- Pellet
- Class
- Hepatitis C Virus Nucleotide Analog NS5…
Gilead Sciences, Inc.
Sovaldi
SOFOSBUVIR
Listed by Gilead Sciences, Inc.
- Strength
- 400 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Hepatitis C Virus Nucleotide Analog NS5B Poly…
What it contains
- Sofosbuvir 400 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 61958-1501 |
| FDA application | NDA204671 |
| RxNorm concept | 1484916 |
| Package sizes listed | 1 |
| Marketed since | December 2013 |
Other products containing Sofosbuvir
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Sovaldi
SOFOSBUVIR
- Strength
- 200 mg/1
- Form
- Pellet
- Class
- Hepatitis C Virus Nucleotide Analog NS5…
Gilead Sciences, Inc.
Sovaldi
SOFOSBUVIR
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis C Virus Nucleotide Analog NS5…
Gilead Sciences, Inc.
Vosevi
SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR
- Strength
- 400 mg/1, 100 mg/1, 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis C Virus NS3/4A Protease Inhib…
Gilead Sciences, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.